Amir Heshmatpour
Tracked across 3 events · 19 articles · First seen Apr 07, 2026 · Last active Aug 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Amir Heshmatpour, CEO of Neonci Technologies, has consistently purchased shares, signaling management's confidence in the company's future and upcoming clinical data.
May 19, 2026 · 6 articles
Regulatory
Impact: Amir Heshmatpour, Chairman, President, and CEO of Neonci Technologies, has been actively buying company stock, indicating confidence in the company's long-term strategy and development prospects.
Jun 16, 2026 · 6 articles
Business
Neonci Technologies reported positive topline results from its NEO100-01 Phase 2a study in patients with recurrent or progressive Grade III and Grade IV IDH1-mutant glioma. The study met its primary endpoint with 48.9% six-month progression-free…
Impact: CEO Amir Heshmatpour's continued open-market purchases signal management conviction, positively reflecting on the company.
Aug 26, 2026 · 7 articles
40
Amir Heshmatpour purchased shares Neonci TechnologiesNeOnc NEO100 Phase 2a Results
ERGEN INTELLIGENCE
Track Amir Heshmatpour live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard